Is Bausch Health Companies Inc (NYSE: BHC) Worth What Its Shareholders Think It Is?

During the last session, Bausch Health Companies Inc (NYSE:BHC)’s traded shares were 2.79 million, with the beta value of the company hitting 0.90. At the end of the trading day, the stock’s price was $8.62, reflecting an intraday gain of 0.70% or $0.06. The 52-week high for the BHC share is $11.46, that puts it down -32.95 from that peak though still a striking 35.38% gain since the share price plummeted to a 52-week low of $5.57. The company’s market capitalization is $3.15B, and the average trade volume was 2.80 million shares over the past three months.

Bausch Health Companies Inc (NYSE:BHC) trade information

Bausch Health Companies Inc (BHC) registered a 0.70% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.70% in intraday trading to $8.62, hitting a weekly high. The stock’s 5-day price performance is 0.23%, and it has moved by -12.58% in 30 days. Based on these gigs, the overall price performance for the year is 21.07%.

Bausch Health Companies Inc (BHC) estimates and forecasts

Statistics show that Bausch Health Companies Inc has underperformed its competitors in share price, compared to the industry in which it operates. Bausch Health Companies Inc (BHC) shares have gone up 20.56% during the last six months, with a year-to-date growth rate less than the industry average at 13.18% against 21.80. In the rating firms’ projections, revenue will increase 7.20% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 2.14B as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 2.35B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 1.97B and 2.17B respectively. In this case, analysts expect current quarter sales to grow by 9.10% and then jump by 8.30% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 32.76%. While earnings are projected to return 12.75% in 2024, the next five years will return 2.60% per annum.

BHC Dividends

Bausch Health Companies Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Bausch Health Companies Inc (NYSE:BHC)’s Major holders